Rotarix vaccine oral syringe 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,273
Award facts
- Contract value 100% obligated
- $21,273.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,273.30 to AmerisourceBergen Drug Corp for the procurement of Rotarix Vaccine Oral Syringe 1.5ML, with an ultimate completion date of January 23, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This award represents a task order under a larger Indefinite Delivery Contract vehicle held by the parent company Cencora, Inc. with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support program for military healthcare operations.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies and medications to federal agencies, particularly the Department of Defense and Defense Health Agency. The company's portfolio includes vaccines, specialty medications, brand-name and generic drugs, and various medical devices across multiple therapeutic domains. The Rotarix vaccine procurement supports the Defense Logistics Agency's mission to supply essential pharmaceutical commodities to military treatment facilities and veterans' healthcare programs worldwide. This specific delivery order contributes to the broader pharmaceutical prime vendor program that enables flexible and comprehensive medical supply chain support across federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFL3A?
SPE2DR26FFL3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FFL3A worth?
The government has obligated $21,273 on SPE2DR26FFL3A.
Is contract SPE2DR26FFL3A an order under another contract?
Yes. SPE2DR26FFL3A is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL3A competed?
The extent of competition for SPE2DR26FFL3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award